Intrinsic K-Ras dynamics: A novel molecular dynamics data analysis method shows causality between residue pair motions
暂无分享,去创建一个
[1] Ruth Nussinov,et al. The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. , 2016, Current opinion in structural biology.
[2] B. Erman. Effects of ligand binding upon flexibility of proteins , 2015, Proteins.
[3] Igor N. Berezovsky,et al. Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication , 2016, PLoS Comput. Biol..
[4] P. Kollman,et al. A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .
[5] V. Hilser,et al. The ensemble nature of allostery , 2014, Nature.
[6] Yi Liu,et al. Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. , 2016, Cancer discovery.
[7] Alex Travesset,et al. Differential dynamics of RAS isoforms in GDP‐ and GTP‐bound states , 2015, Proteins.
[8] V. Hornak,et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.
[9] R. Nussinov,et al. Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region* , 2015, The Journal of Biological Chemistry.
[10] Takashi Kumasaka,et al. Structural Basis for Conformational Dynamics of GTP-bound Ras Protein* , 2010, The Journal of Biological Chemistry.
[11] Simon Scheuring,et al. Mechanics of proteins with a focus on atomic force microscopy , 2013, Journal of Nanobiotechnology.
[12] Piotr Cieplak,et al. The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building. , 2010, Physical chemistry chemical physics : PCCP.
[13] Hans Robert Kalbitzer,et al. Conformational States of Human Rat Sarcoma (Ras) Protein Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and GTP Hydrolysis* , 2010, The Journal of Biological Chemistry.
[14] C. Granger. Investigating causal relations by econometric models and cross-spectral methods , 1969 .
[15] J. K. Cheong,et al. The renewed battle against RAS-mutant cancers , 2016, Cellular and Molecular Life Sciences.
[16] C. Mattos,et al. DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site. , 2014, Journal of molecular biology.
[17] Taebo Sim,et al. Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor. , 2014, Angewandte Chemie.
[18] Priyanka Prakash,et al. The Role of Conserved Waters in Conformational Transitions of Q61H K-ras , 2012, PLoS Comput. Biol..
[19] J Andrew McCammon,et al. A novel switch region regulates H‐ras membrane orientation and signal output , 2008, The EMBO journal.
[20] Thorsten Graf,et al. Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes. , 2010, Angewandte Chemie.
[21] J Andrew McCammon,et al. Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins. , 2008, Structure.
[22] J Andrew McCammon,et al. Conformational selection in G-proteins: lessons from Ras and Rho. , 2010, Biophysical journal.
[23] E D Laue,et al. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. , 1997, Biochemistry.
[24] Jenn-Kang Hwang,et al. Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations , 2013, PloS one.
[25] Piotr Cieplak,et al. R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments , 2011, Nucleic Acids Res..
[26] H. Kalbitzer,et al. A novel mechanism for the modulation of the Ras-effector interaction by small molecules. , 2005, Biochemical and biophysical research communications.
[27] D. Kern,et al. The role of dynamics in allosteric regulation. , 2003, Current opinion in structural biology.
[28] Frank Noé,et al. Automated computation of low‐energy pathways for complex rearrangements in proteins: Application to the conformational switch of Ras p21 , 2005, Proteins.
[29] I. Bahar,et al. Gaussian Dynamics of Folded Proteins , 1997 .
[30] Ruth Nussinov,et al. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site* , 2015, The Journal of Biological Chemistry.
[31] On the dynamic origins of allosteric activation. , 2001 .
[32] Ozlem Keskin,et al. GTP-Dependent K-Ras Dimerization. , 2015, Structure.
[33] Y. Engelborghs,et al. Molecular dynamics simulation of the solution structures of Ha-ras-p21 GDP and GTP complexes: flexibility, possible hinges, and levers of the conformational transition. , 1995, Biochemistry.
[34] Sheng Li,et al. Phosphorylation-induced Conformational Changes in Rap1b , 2009, The Journal of Biological Chemistry.
[35] G. Zaccai,et al. How soft is a protein? A protein dynamics force constant measured by neutron scattering. , 2000, Science.
[36] Ruth Nussinov,et al. Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm , 2015, PLoS Comput. Biol..
[37] Priyanka Prakash,et al. Lessons from computer simulations of Ras proteins in solution and in membrane. , 2013, Biochimica et biophysica acta.
[38] Kevan M. Shokat,et al. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions , 2013, Nature.
[39] D. Longo,et al. Improving Prospects for Targeting RAS. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] H. Varmus,et al. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.
[41] D. Esposito,et al. Dragging ras back in the ring. , 2014, Cancer cell.
[42] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[43] A. Lièvre,et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.
[44] Suryani Lukman,et al. The Distinct Conformational Dynamics of K-Ras and H-Ras A59G , 2010, PLoS Comput. Biol..
[45] M. Buck,et al. Combining NMR and molecular dynamics studies for insights into the allostery of small GTPase-protein interactions. , 2012, Methods in molecular biology.
[46] L. Perkins,et al. Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex. , 1997, Bioorganic & medicinal chemistry.
[47] Ruth Nussinov,et al. The higher level of complexity of K‐Ras4B activation at the membrane , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] Schreiber,et al. Measuring information transfer , 2000, Physical review letters.
[49] A. Gorfe,et al. Ras membrane orientation and nanodomain localization generate isoform diversity , 2010, Proceedings of the National Academy of Sciences.
[50] Ruth Nussinov,et al. Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. , 2016, Chemical Society reviews.
[51] Norbert Perrimon,et al. Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices , 2015, Proceedings of the National Academy of Sciences.
[52] James Andrew McCammon,et al. Ras Conformational Switching: Simulating Nucleotide-Dependent Conformational Transitions with Accelerated Molecular Dynamics , 2009, PLoS Comput. Biol..
[53] I. Vetter,et al. The Guanine Nucleotide-Binding Switch in Three Dimensions , 2001, Science.
[54] Kendra Marcus,et al. Direct Attack on RAS: Intramolecular Communication and Mutation-Specific Effects , 2015, Clinical Cancer Research.
[55] Priyanka Prakash,et al. Binding hotspots on K‐ras: Consensus ligand binding sites and other reactive regions from probe‐based molecular dynamics analysis , 2015, Proteins.
[56] N. Goodey,et al. Allosteric regulation and catalysis emerge via a common route. , 2008, Nature chemical biology.
[57] J. Howard,et al. Mechanics of Motor Proteins and the Cytoskeleton , 2001 .
[58] Neal Rosen,et al. Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism , 2016, Science.
[59] H. Kamberaj,et al. Extracting the causality of correlated motions from molecular dynamics simulations. , 2009, Biophysical journal.
[60] C. Mattos,et al. Allosteric modulation of Ras positions Q61 for a direct role in catalysis , 2010, Proceedings of the National Academy of Sciences.
[61] Mingming Jia,et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..
[62] Harrison J. Hocker,et al. Novel Allosteric Sites on Ras for Lead Generation , 2011, PloS one.
[63] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[64] S. Rodenhuis,et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.
[65] Francesca Fanelli,et al. Nucleotide Binding Switches the Information Flow in Ras GTPases , 2011, PLoS Comput. Biol..
[66] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[67] Dima Kozakov,et al. Analysis of binding site hot spots on the surface of Ras GTPase. , 2011, Journal of molecular biology.
[68] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[69] Martin Karplus,et al. The elastic properties of the structurally characterized myosin II S2 subdomain: a molecular dynamics and normal mode analysis. , 2008, Biophysical journal.